Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Glibenclamide
- Therapeutic area
- Endocrine & metabolic
- Drug class
- Antidiabetic medicines
- ATC
- A10
- Strength
- 5 mg
- Dosage form
- Tablet
- Pack
- 25 x 20’s
- Registration no.
- 032859
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 1,074.28 to 1,150.02 (+7.1%) between 5 Nov 2025 and 17 Aug 2026 · 2 official price records · pack 25 x 20’s
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Glucoban 5 mg, 25 x 20’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/glucoban-5-mg-032859-25-x-20s-mega-pharmaceuticals-limited-10625/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,150.02 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 1,074.28 | 2025-11-05 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 032859Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
